Kidney disease in hepatitis B surface antigen-positive children: experience from a centre in south-west Nigeria and a review of the Nigerian literature

References

• Elewa U, Sandri AM, Kim WR, et al. Treatment of hepatitis B virus-associated nephropathy. Nephron Clin Pract. 2011;119:c41–c49; discussion c9.10.1159/000324652
   PubMedGoogle Scholar
• Bhimma R, Coovadia HM. Hepatitis B virus-associated nephropathy. Am J Nephrol. 2004;24:198–211.10.1159/000077065
   PubMed Web of Science ®Google Scholar
• Manna A, Polito C, Del Gado R, et al. Hepatitis B surface antigenaemia and glomerulopathies in children. Acta Paediatr Scand. 1985;74:122–125.10.1111/apa.1985.74.issue-1
   PubMed Web of Science ®Google Scholar
• Levy M, Kleinknecht C. Membranous glomerulonephritis and hepatitis B virus infection. Nephron. 1980;26:259–65.
   PubMed Web of Science ®Google Scholar
• Pena A, Debora MJ, Melgosa M, et al. Membranous nephropathy associated with hepatitis B in Spanish children. Clin Nephrol. 2001;55:25–30.
   PubMed Web of Science ®Google Scholar
• Bhimma R, Coovadia HM, Adhikari M. Hepatitis B virus-associated nephropathy in black South African children. Pediatr Nephrol. 1998;12:479–484.10.1007/s004670050492
   PubMed Web of Science ®Google Scholar
• Gilbert RD, Wiggelinkhuizen J. The clinical course of hepatitis B virus-associated nephropathy. Pediatr Nephrol. 1994;8:11–14.10.1007/BF00868249
   PubMed Web of Science ®Google Scholar
• Hsu HC, Lin GH, Chang MH, et al. Association of hepatitis B surface (HBs) antigenemia and membranous nephropathy in children in Taiwan. Clin Nephrol. 1983;20:121–9.
   PubMed Web of Science ®Google Scholar
• Lai KN, Lai FM, Chan KW, et al. The clinico-pathologic features of hepatitis B virus-associated glomerulonephritis. Q J Med. 1987;63:323–33.
   PubMedGoogle Scholar
• Abdurrahman MB, Fakunle YM, Whittle HC. The role of hepatitis B surface antigen in Nigerian children with nephrotic syndrome. Ann Trop Paediatr. 1983;3:13–16.10.1080/02724936.1983.11748261
   PubMedGoogle Scholar
• Seggie J, Nathoo K, Davies PG. Association of hepatitis B (HBs) antigenaemia and membranous glomerulonephritis in Zimbabwean children. Nephron. 1984;38:115–19.
   PubMed Web of Science ®Google Scholar
• Musa BM, Samaila AA, Borodo MM, et al. Prevalence of hepatitis B virus infection in Nigeria, 2000-2013: A systematic review and meta-analysis. Niger J Clin Pract. 2015;18:163–72.10.4103/1119-3077.151035
   PubMed Web of Science ®Google Scholar
• Sadoh AE, Ofili A. Hepatitis B infection among Nigerian children admitted to a children’s emergency room. Afr Health Sci. 2014;14:377–83.10.4314/ahs.v14i2.13
   PubMed Web of Science ®Google Scholar
• Sadoh A, Sadoh W. Serological markers of hepatitis B infection in infants presenting for their first immunisation. Niger J Paediatr. 2013;40:248–53.
   Google Scholar
• Sadoh A, Sadoh W. Does Nigeria need the birth dose of the hepatitis B vaccine? Niger J Paediatr. 2014;41:104–9.10.4314/njp.v41i2.5
   Google Scholar
• Asinobi AO, Ademola AD, Ogunkunle OO, et al. Paediatric end-stage renal disease in a tertiary hospital in South West Nigeria. BMC Nephrol. 2014;15:692.10.1186/1471-2369-15-25
   Web of Science ®Google Scholar
• Ladapo TA, Esezobor CI, Lesi FE. High steroid sensitivity among children with nephrotic syndrome in Southwestern Nigeria. Int J Nephrol. 2014;2014:350640.
   PubMedGoogle Scholar
• Ladapo TA, Onifade EU, Lesi AE, et al. Successful treatment of hepatitis B virus associated nephrotic syndrome with oral lamivudine in a nigerian child: a case report. J Trop Pediatr. 2012;58:157–158.10.1093/tropej/fmr046
   PubMed Web of Science ®Google Scholar
• Anochie I, Eke F. Chronic renal failure in children: a report from Port Harcourt, Nigeria (1985–2000). Pediatr Nephrol. 2003;18:692–5.
   PubMed Web of Science ®Google Scholar
• Asinobi AO, Ademola AD, Okolo CA, et al. Trends in the histopathology of childhood nephrotic syndrome in Ibadan Nigeria: preponderance of idiopathic focal segmental glomerulosclerosis. BMC Nephrol. 2015;16:186.10.1186/s12882-015-0208-0
   PubMed Web of Science ®Google Scholar
• Ademola AD, Asinobi AO, Ogunkunle OO, et al. Peritoneal dialysis in childhood acute kidney injury: experience in Southwest Nigeria. Perit Dial Int. 2012;32:267–272.10.3747/pdi.2011.00275
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl. 2012;2:139–274.
   Web of Science ®Google Scholar
• National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–76.
   PubMed Web of Science ®Google Scholar
• Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2013(3):1–150.
   Google Scholar
• Okonko I, Okeretugba P. Innocent-Adiele H. Detection of hepatitis B surface antigen (HBSAg) among children in Ibadan, Southwestern Nigeria [Internet]. J Infect Dis. 2012;10. Available from: http://ispub.com/IJID/10/1/14183
   Google Scholar
• Ozdamar SO, Gucer S, Tinaztepe K. Hepatitis B virus associated nephropathies: a clinicopathological study in 14 children. Pediatr Nephrol. 2003;18:23–28.10.1007/s00467-002-0978-z
   PubMed Web of Science ®Google Scholar
• Elidrissy A, Abdurrahman M, Ramia S, et al. Hepatitis B surface antigen associated nephrotic syndrome. Ann Trop Paediatr. 1988;8:157–161.10.1080/02724936.1988.11748560
   PubMed Web of Science ®Google Scholar
• Ring-Larsen H, Palazzo U. Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosis. Gut. 1981;22:585–591.10.1136/gut.22.7.585
   PubMed Web of Science ®Google Scholar
• Kishi T, Ikeda Y, Takashima T, et al. Acute renal failure associated with acute non-fulminant hepatitis B. World J Hepatol. 2013;5:82–5.10.4254/wjh.v5.i2.82
   PubMedGoogle Scholar
• Francis TI, Smith JA. Australia antigen in Nigerian blood donors and school children. Br Med J. 1971;4:683–684.10.1136/bmj.4.5788.683-c
   PubMedGoogle Scholar
• Fakunle YM, Abdurrahman MB, Whittle HC. Hepatitis B virus infection in children and adults in Northern Nigeria: a preliminary survey. Trans R Soc Trop Med Hyg. 1981;75:626–629.10.1016/0035-9203(81)90133-4
   PubMed Web of Science ®Google Scholar
• Johnson A, Sodeinde O, Odeola H, et al. Survey of hepatitis A and B infections in childhood in Ibadan – preliminary study. Niger J Paediatr. 1986;13:83–6.
   Google Scholar
• Abiodun PO, Fatunde OJ, Flach KH, et al. Increased incidence of hepatitis B markers in children with sickle-cell anemia. Blut. 1989;58:147–150.10.1007/BF00320435
   PubMedGoogle Scholar
• Abiodun P, Omoike I. Hepatitis B surface antigenaemia in children in Benin City, Nigeria. Niger J Paediatr. 1990;17:27–31.
   Google Scholar
• Angyo AI, Okuonghae HO, Szlachetka R, et al. Hepatitis B surface antigenaemia in Jos. Niger J Paed. 1995;22:42–6.
   Google Scholar
• Angyo I, Yakubu A. Lack of association between some risk factors and hepatitis B surface antigenaemia in children with sickle cell anaemia. West Afr J Med. 2000;20:214–18.
   Google Scholar
• Chukwuka J, Ezechukwu C, Egbouonu I, et al. Prevalence of hepatitis B surface antigen in primary school children in Nnewi, Nigeria. Niger J Clin Pract. 2004;7:8–10.
   Google Scholar
• Bukbuk DN, Bassi AP, Mangoro ZM. Sero-prevalence of hepatitis B surface antigen among primary school pupils in rural Hawal valley, Borno State, Nigeria. J Community Med Primary Health Care. 2005;17:20–3.
   Google Scholar
• Odusanya OO, Alufohai FE, Meurice FP, et al. Prevalence of hepatitis B surface antigen in vaccinated children and controls in rural Nigeria. Int J Infect Dis. 2005;9:139–143.10.1016/j.ijid.2004.06.009
   PubMed Web of Science ®Google Scholar
• Agbede OO, Iseniyi JO, Kolawole MO, et al. Risk factors and seroprevalence of hepatitis B surface antigenemia in mothers and their preschool age children in Ilorin, Nigeria. Therapy. 2007;4:67–72.
   Google Scholar
• Alikor EA, Erhabor ON. Seroprevalence of hepatitis B surface antigenaemia in children in a tertiary health institution in the Niger Delta of Nigeria. Niger J Med. 2007;16:326–9.
   PubMedGoogle Scholar
• Onakewhor JU, Offor E, Okonofua FE. Maternal and neonatal seroprevalence of hepatitis B surface antigen (HBsAg) in Benin City, Nigeria. J Obstet Gynaecol. 2001;21:583–586.10.1080/01443610120085528
   PubMedGoogle Scholar
• Ugwuja E, Ugwu N. Seroprevalence of hepatitis B surface antigen and liver function tests among adolescents in Abakaliki, South Eastern Nigeria. Internet J Trop Med. 2010;6:1726–32.
   Google Scholar
• Adoga MP, Gyar SD, Pechulano S, et al. Hepatitis B virus infections in apparently healthy urban Nigerians: data from pre-vaccination tests. J Infect Dev Ctries. 2010;4:397–400.
   PubMed Web of Science ®Google Scholar
• David O, Oluduro A, Ariyo A, et al. Sero-epidemiological survey of hepatitis B surface antigenemia in children and adolescents in Ekiti State, Nigeria. J Public Health Epidemiol. 2012;5:11–14.
   Google Scholar
• Jibrin B, Jiya NM, Ahmed H. Prevalence of hepatitis B surface antigen in children with sickle cell anemia. Sahel Med J. 2014;17:15.10.4103/1118-8561.129147
   Google Scholar
• Ikobah J, Okpara H, Elemi I, et al. The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme on Immunisation schedule. Pan Afr Med J. 2016;23:128.
   PubMed Web of Science ®Google Scholar
• Nwokedi EO, Odimayo MS, Emokpae AM, et al. Seroprevalence of hepatitis B surface antigen among patients attending Aminu Kano Teaching Hospital, Kano. Niger J Med. 2010;20:213–15.
   Google Scholar
• Bukbuk D, Denue B, Ngoshe I, et al. Hepatitis B surface antigenaemia among high risk groups in northeastern Nigeria. Niger Med Pract. 2016;69:77–82.
   Google Scholar